Sequential eradicating therapy: A treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia? [8]

American Journal of Gastroenterology

Volumn 97, Issue 10, 2002, Pages 2686-2687

  De Francesco, Vincenzo ^a   Faleo, Domenico ^a   Panella, Carmen ^b   Ierardi, Enzo ^b   Margiotta, Marcella ^c  

^a AOU Ospedali Riuniti   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; RABEPRAZOLE; TINIDAZOLE;

BACTERIAL STRAIN; CYTOTOXICITY; DRUG EFFICACY; DUODENOSCOPY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FISHER EXACT TEST; GENOTYPE; GEOGRAPHY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; IMMUNOCHEMISTRY; LETTER; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0036790724     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04420-9     Document Type: Letter

References (12)

1. Huang JQ, Hunt RH. Are one-week anti-Helicobacter pylori treatments more effective in patients with peptic ulcer disease than in those with nonulcer dyspepsia? A meta-analysis. Am J Gastroenterol 1998;93:1639.
2. De Francesco V, Ierardi E, Afferrante T, et al. Helicobacter pylori eradication rates in nonulcer dispepsia and duodenal ulcer patients. Dig Liver Dis 2001;33 (suppl 1):A83.
3. Gisbert JP, Marcos S, Gisbert JS, et al. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in nonulcer dyspepsia. Eur J Gastroenterol Hepatol 2001;13:1303-7.
4. de Boer WA, Tytgat GN. Should anti Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis? Eur J Gastroenterol Hepatol 2001;13:1281-4.
5. Van Doom LJ, Schneeberger PM, Nohuan N, et al. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 2000;46:321-6.
6. Broutet N, Marais A, Lamouliatte H, et al. CagA status and eradication outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol 2001;38:1319-22.
7. Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14:715-8.
8. De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori: A randomised study. Dig Liver Dis 2001;33:676-9.
9. Rutigliano V, Ierardi E, Francavilla R, et al. Helicobacter pylori and nonulcer dyspepsia in childhood: Clinical pattern, diagnostic techniques and bacterial strains. J Pediatr Gastroenterol Nutr 1999;28:280-6.
10. Yamaoka Y, Graham DY. CagA status and gastric cancer: Unreliable serological tests produce unreliable data. Gastroenterology 1999;117:745.
11. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
12. Fox JG, Wang TC. Helicobacter pylori: Not a good bug after all! N Engl J Med 2001;345:824-9.